Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- TRVN
- Price
- 1.12
- Stock movement down
- -0.06 (-5.08%)
- Company name
- Trevena Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 967.44K
- Ent value
- 30.00M
- Price/Sales
- 1.54
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -21.28%
- 1 year return
- -88.60%
- 3 year return
- -83.69%
- 5 year return
- -69.89%
- 10 year return
- -56.14%
Last updated: 2025-04-18
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
TRVN does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 1.54 |
| Price to Book | - |
| EV to Sales | 47.77 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 863.79K |
| EPS (TTM) | -20.53 |
| FCF per share (TTM) | -20.75 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 628.00K |
| Gross profit (TTM) | 146.00K |
| Operating income (TTM) | -21.96M |
| Net income (TTM) | -17.51M |
| EPS (TTM) | -20.53 |
| EPS (1y forward) | -0.90 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 23.25% |
| Operating margin (TTM) | -3496.50% |
| Profit margin (TTM) | -2787.90% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 13.46M |
| Net receivables | 0.00 |
| Total current assets | 14.73M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 4.11M |
| Total assets | 19.19M |
| Accounts payable | 918.00K |
| Short/Current long term debt | 2.00M |
| Total current liabilities | 6.09M |
| Total liabilities | 42.50M |
| Shareholder's equity | -23.31M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -21.11M |
| Capital expenditures (TTM) | 21.00K |
| Free cash flow (TTM) | -17.69M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -91.24% |
| Return on Invested Capital | -164.13% |
| Cash Return on Invested Capital | -165.86% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.12 |
| Daily high | 1.12 |
| Daily low | 1.12 |
| Daily Volume | 0K |
| All-time high | 8312.50 |
| 1y analyst estimate | 52.50 |
| Beta | 1.02 |
| EPS (TTM) | -20.53 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 13 May 2025 |
Downside potential
Loading...
Downside potential data
| TRVN | S&P500 | |
| Current price drop from All-time high | -99.99% | -14.12% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 11 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -77.52% | -11.07% |
| Avg time to new high | 217 days | 12 days |
| Max time to new high | 2409 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
967.44K
Marketcap category
Small-cap
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.
Employees
23
Website
Investor relations
-
SEC filings
CEO
Carrie L. Bourdow
Country
USA
City
Chesterbrook
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page